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Sjögren’s Syndrome is an autoimmune disease of the
exocrine glands, mainly salivary and lachrymal glands. There
is no gold standard test for diagnosis. Aim: evaluation of the
importance of minor salivary gland biopsy and sialometry,
isolated or associated, as methods for classification of Sjögren’s
Syndrome. Study design: Transversal cohort. Patients and
Method: Seventy-two patients that reported dry mouth from
January 1997 to September 2003 were investigated and
classified, based on the established criteria. Non-stimulated
sialometry was performed by the swab technique.
Histopathology exams were evaluated for the presence of
inflammatory focus. Results: Non-stimulated sialometry and
minor salivary gland biopsy presented different sensitivities
for primary Sjögren’s Syndrome and for secondary Sjögren’s
Syndrome. Focal sialadenitis with higher focus score was
characteristic of primary Sjögren’s Syndrome. Biopsy and
sialometry were compared and it was observed that
specificity and positive predictive value of biopsy were
higher. Comparing biopsy and biopsy associated with
sialometry, it was observed that biopsy had higher sensitivity
and negative predictive value. Specificity of biopsy
associated with sialometry was higher. Comparing sialometry
and biopsy associated with sialometry, it was observed that
biopsy associated with sialometry presented higher positive
predictive value and higher specificity. Sialometry’s
sensitivity was higher. Conclusions: Sialometry and biopsy
tests presented different performances in primary Sjögren’s
Syndrome and secondary Sjögren’s Syndrome; the positivity
of the association of both tests increases the specificity for
Sjögren’s Syndrome (95%).
Key words: Sjögren's syndrome, xerostomia,
salivary glands, saliva, diagnosis.
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INTRODUCTION
Sjögren’s Syndrome is an autoimmune affection of
the exocrine glands that involves salivary and lachrymal
glands. The clinical spectrum is broad and it may range
from reduction of lachrymation and xerostomia to joint,
pulmonary and renal impairment. Primary Sjögren’s
Syndrome takes placed isolated and secondary Sjögren’s
Syndrome (SS) manifests concomitantly with other
autoimmune diseases, especially lupus and rheumatoid
arthritis.1
SS affects mainly female patients with prevalence of
9 women to 1 man, and age of symptom onset is about 40
to 45 years. It is rare in children 2. Mean age at diagnosis is
50 years 3. Its real prevalence is hard to be defined as a
result of the difficulty to diagnose it, but it is estimated to be
1% to 3% of the population1.
There is a tissue inflammatory infiltrate that affects
target organs, normally comprised in most cases (60 to70%)
by T CD4 lymphocytes and by a minority of lymphocytes
B. However, there is hyperreactivity of B cells with mono
or polyclonal production of IgM or IgG immunoglobulins.
Epithelial cells of salivary glands express cytokines such as
interleukin 1E, interleukin 6 and TNFD. Autoimmune
response is directed to rhibonucleoproteins Ro/SS-A with
two protein chains of 52 and 60 kDa (cytoplasm) and La/
SS-B (nuclear) of 48 kDa. The mechanism that may be
responsible for the autoimmune process is apoptosis of
epithelial cell, in which intracellular auto-antigens are
exposed to the immune system on the surface of the
apoptotic blisters 4.
More than one third of patients have systemic
manifestations that can include vasculitis, cryoglobulinemia,
autoimmune hepatitis, pulmonary fibrosis, central nervous
system impairment, renal tubular acidosis, B cell
lymphoma and multiple myeloma 1,2,4. Thus, the
appropriate diagnosis of the manifestation is important
to provide symptom relief 3 but also clinical follow up of
the possible complications, considering that those are late
events in the syndrome 5.
Saliva has an important role in gustation, mastication,
swallowing and speech, as a result of the lubricant role in
the oral cavity; in addition, many enzymes that comprise
saliva act as antimicrobial agent 6. The reduction of saliva
leads to repercussions in swallowing and speech, with
complications such as erythematous candidiasis and tooth
decays.
Many studies tried to define classification criteria
for Sjögren’s Syndrome considering that there is no final
diagnostic exam. Such criteria started to be employed in
different services, hindering the interpretation of
international literature. A multicenter study performed
in 12 countries, guided by The European Community
Study Group on Diagnostic Criteria for Sjögren’s
Syndrome, tried to define reliable criteria to standardize
diagnoses 1, 7, 8. For primary Sjögren’s Syndrome, there
should be 4 positive criteria out of 6. For secondary
Sjögren’s Syndrome, the presence of 3 specific criteria
is enough.
The sialometry technique used in the European
Community Study Group on Diagnostic Criteria for
Sjögren’s Syndrome is a collection of non-stimulated sali-
va for 15 minutes and 5-minute collection after chewing
paraffin to ensure saliva stimulation. Non-stimulated
sialometry is preferred because it has less influence of
the age of subjects 1,7.
Positivity of autoantibodies ranges at about 70% for
anti-SSA and 60% for anti-SSB according to the methods used
for detection.
Minor salivary gland biopsy is the most accurate exam
8, but it is not a sine qua non criterion for the diagnosis of
Sjögren’s Syndrome and together with the autoantibodies,
they are considered the most specific exams. In past years,
many studies have been directed to non-invasive methods
for the diagnosis of Sjögren’s Syndrome especially by the
dosage of substances present in the inflammatory process
of saliva and tears. However, there are still no definite
studies that validate their use as diagnostic criterion. Other
imaging exams, such as magnetic resonance sialography,
have been studied as non-invasive alternatives for traditional
sialography, trying to avoid the possible complications that
include duct trauma, pain upon contrast injection and
allergic reaction.
The participation of the Otorhinolaryngologist is
essential for the diagnosis, not only to perform minor salivary
gland biopsy but also to assess gland involvement, always
trying to perform less invasive exams. The technique of
sialometry with cotton weighing that has been used in our
center 9 has proven to be easy and practical to perform
compared to other methods and it is less invasive than parotid
sialography.
In daily practice, the diagnosis of Sjögren’s
Syndrome can be made based only on clinical impressions,
but to include a patient in scientific studies, it is necessary
to have diagnostic confirmation through the criteria
obtained from the clinical history and objective
complementary exams 10, 11.
The present study aimed at assessing the role of
minor salivary gland biopsy and sialometry, either isolated
or associated, as methods used to classify Sjögren’s
Syndrome based on the criteria defined by the European
Community Study Group on Diagnostic Criteria for
Sjögren’s Syndrome 1,7,8,11,12.
MATERIAL AND METHOD
All 72 patients complaining of dry mouth that came
to the Department of Otorhinolaryngology, Santa Casa de
348
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 71 (3) PART 1 MAY/JUNE 2005
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
São Paulo, from January 1997 to September 2003, were
clinically assessed at the Ambulatory of Stomathology and
they were submitted to diagnostic investigation and
classification based on the criteria defined by the American-
European Consensus 11 (Chart 1).
These patients were divided into 2 groups: the group
that did not present Sjögren’s Syndrome (NSS) and the group
that had Sjögren’s Syndrome (SS). The group that had SS
was divided into 2 subgroups: with primary Sjögren’s
Syndrome (SSp) and secondary Sjögren’s Syndrome (SSsec).
To classify patients with primary Sjögren’s Syndrome
we required the presence of 4 out of 6 items and item 4
(histopathology) or 6 (auto-antibodies) had necessarily to
be present. As to classification of patients with secondary
Sjögren’s Syndrome, it required the presence of item 1 or
item 2 plus 2 other items numbered 3, 4 and 5 (Chart 1).
We considered as exclusion criteria for classification
of Sjögren’s Syndrome: previous head and neck radiotherapy;
Hepatitis C; AIDS; preexisting lymphoma; sarcoidosis; graft
versus host disease; use of anti-cholinergic drugs. We
excluded from the study one patient that had Wegener’s
granulomatosis.
The progression of the disease was considered as
the period between onset of symptoms and first visit at
the Ambulatory of Stomathology, Department of
Otorhinolaryngology.
Non-stimulated sialometry was performed with sali-
va collection technique using two cotton balls that had been
previously weighted with the 80ml universal collection
container, using a regular digital scale. Patients were instructed
to swallow all saliva they had in the oral cavity and then the
cotton balls were placed on the floor of the mouth, close to
the gingival border, where they remained for 2 minutes.
After this time, the set was weighted again. The difference
in weight was transformed from g/min directly into ml/minute
and any sialometry that had value below 0.1 ml/minute was
considered abnormal.
The technique of minor salivary gland biopsy,
chosen as the preferred one, was performed with a hori-
zontal incision on the mucous face of the lower lip parallel
to the lip vermillion, with removal of 4 to 6 minor salivary
glands, but no removal of lip mucosa. This material was
placed in containers with 10% formol, processed with
paraffin inclusion, submitted to sections of rotation
microtome, producing 3-micrometer thick sections.
Sections were stained with hematoxylin-eosin (HE) and
submitted to histology analysis. The slides were later
reviewed using a Zeiss microscope model Axioskop 40,
coupled to a computer with Intel Pentium III processor
and supported by software Axiovision 3.1, to limit the
gland area tissue. In this review, the glandular tissue was
measured using a cursor in different fields, with 50X
enlargement, and histopathological analyses were classified
based on presence of inflammatory infiltrate and presence
of inf lammatory foci ,  which consis ted on 50
lymphocytarian cell agglomerates. Foci count in the total
Chart 1. Criteria for classification of Sjögren’s Syndrome.
I. Ocular symptoms, positive response for at least one of the following questions:
1. Have you felt your eyes dry for the past 3 months?
2. Do you have a recurrent feeling of sand in the eyes?
3. Do you use tear substitutes more than 3 times a day?
II. Oral symptoms, positive response to at least one of the following questions:
1. Have you felt your mouth dry for the past 3 months?
2. Have you had recurrent or persistent increase in salivary glands in adult life?
3. Do you normally drink liquids to help you swallow dry foods?
III. Ocular impairment signs, positive results in one of the two following tests:
x Schirmer I Test (< or = 5 mm within 5 min);
x Rose Bengal or other dye test (> or = 4).
IV. Histopathology: presence of 1 or more foci (agglomerate of 50 or more inflammatory cells) by 4mm2 of gland tissue in minor salivary
gland biopsy.
V. Salivary gland involvement, positive result for one of the following diagnostic tests:
x Sialometry with total non-stimulated flow < or = 1.5 ml within 15 minutes;
x Parotid Sialography showing diffuse sialectasia, without evidence of major duct obstruction;
x Salivary scintigraphy with delay in recording, reduction in concentration and/or delay in tracing secretion.
VI. Auto-antibodies, presence of one or both:
Anti -Ro antibodies (SS-A) or anti-La antibodies (SS-B).
Source: Vitali et al. (2002).
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area of glandular tissue in each exam was corrected in
each one to correspond to 4mm2. Slides with the
respective areas measured in glandular tissue were
photographed, amounting to 280 photos.
Histopathological findings were graded as follows:
normal gland; mild inflammatory process; moderate
inflammatory process; severe inflammatory process, and
presence of inflammatory foci (Figures 1 and 2).
Based on the selected Statistical Method, we used
minimum, maximum, median, mean and standard deviation
values to describe the quantitative variables and Wilcoxon
test for independent samples and Kruskal-Wallis test for the
comparison between 2 groups and more than 2 groups. In
the case in which we detected statistically significant
difference between the groups, we performed multiple
comparisons using Dunn test to identify the differences.
Pearson correlation coefficient was used to study the
association between number of foci and duration of disease
progression.
We calculated sensitivity, specificity, positive and
negative predictive vales and accuracy of biopsy,
sialometry and the combinations of both results. The
comparison of such indexes between the exams was
made using linear models for categorized data, using
Wald’s statistics. The adopted level of significance was
5%.
The study was approved by the Ethics Committee of
the Institution.
RESULTS
Out of 72 patients with complaints of xerostomia, 26
(36.1%) were classified as having Sjögren’s Syndrome, based
on the presented criteria, and 46 (63.9%) presented different
etiological diagnoses and were classified as non-Sjögren
Syndrome (NSS).
Patients in group SS were divided into 2 subgroups:
17 (65.4%) presented primary Sjögren’s Syndrome and
9 (34.6%), presented secondary Sjögren’s Syndrome
(SSsec).
Out of 46 cases in the NSS group, 7 (15.2%) were
submitted to head and neck radiotherapy; 3 (6.5%) had had
diagnosis of diabetes; 3 (6.5%) presented positive serology
for hepatitis C; 12 (26.1%) made use of xerostomia drugs; 6
(13.1%) had chronic sialadenitis; 1 (2.2%) presented
Wegener’s granulomatosis; 4 (8.7%) met 4 out of 6 criteria
but did not present histopathological diagnosis or positive
auto-antibodies, and 10 cases (21.7%) did not present definite
cause (Figure 10). Out of the patients without definite cau-
se, some are still being investigated and other were lost for
the follow up.
Among the 9 cases of subgroup SSsec, 7 (77.8%) were
secondary to rheumatoid arthritis; 1 (11.1%) was secondary
to lupus; and 1 (11.1%) was secondary to sclerodermia.
As to time of disease progression, the groups
presented: NSS with median 2.00 years (minimum of 0.08
and maximum of 18.00); SSp with median of 4.00 years
(minimum of 0.25 and maximum of 13.00); and SSsec with
median of 3.00 years (minimum of 0,50 and maximum of
7,00), there was no difference between the groups (p =
0.0717). When the analysis was made with the grouping of
subgroups SSp and SSsec, the comparison of group SS with
median of 3.00 years (minimum of 0.25 and maximum of
13.00) with group NSS, showed difference between the two
groups (p = 0.0369).
Analyzing the results of biopsy in relation to
number of inflammatory foci in the groups, we observed
that: in relation to 37 NSS cases, median of 0.00
(minimum of 0.00 and maximum of 6.00); in 17 cases
Figure 1. Presence of inflammatory focus amidst glandular tissue,
indicated by the arrows (HE 100X).
Figure 2. Confluent inflammatory foci indicated by the arrows that
replace the glandular tissue (HE 50X). The red rectangle corresponds
to area measurement.
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SSp, median of 5.20 (minimum of 0.00 and maximum of
12.00); and in 8 cases SSsec, median of 0.00 (minimum
of 0.00 and maximum of 5.90). The comparison between
the groups showed differences relative to number of
foci (p < 0.0001).
Still in relation to number of foci in the biopsy, groups
NSS, SSp and SSsec were compared taking into account the
results of sialometry. When sialometry was abnormal, the
test was considered positive (+) and when normal, it was
considered negative (-). Kruskal-Wallis test showed significant
difference (p = 0.0001) in the comparison of number of foci
in all groups, simultaneously. Multiple comparisons were
made to identify the differences, represented by different
letters (Table 1). Groups with the same letters presented
results without significant differences. Pearson correlation
test was used to correlate the number of biopsy foci with
time of progression, but we did not observe significant results
(r = 0.17330; p = 0.1780).
For biopsy, sialometry and association of the two
criteria -  positive biopsy and sialometry we calculated
sensitivity, specificity, positive and negative predictive values
and accuracy in relation to groups NSS, SSp and SSsec.
To compare indexes of sensitivity, specificity, positive
predictive value, negative predictive value and accuracy,
subgroups SSp and SSsec were gathered and represented
by SS (Table 2).
We compared positive predictive value of biopsy and
sialometry with findings of significant differences between
them (p = 0.0036), and biopsy value was higher than
sialometry value. There was no difference between negative
predictive values (p = 0.0997) and sensitivity (p = 0.5237)
of biopsy and sialometry. Comparing specificity, we observed
that specificity of biopsy was higher than that of sialometry
(p = 0.0106).
Upon comparing the positive predictive value of
biopsy and biopsy associated with sialometry, we
evidenced that there were no significant differences (p
= 0.1553). However, negative predictive values of them
both (p = 0.0129), as well as sensitivity (p = 0.0051) are
different and higher than for biopsy. Specificity of biopsy
and biopsy associated with sialometry presented
significant difference (p = 0.0350), higher for biopsy
associated with sialometry.
Upon comparing positive predictive value of
sialometry and biopsy associated with sialometry, we
observed difference between them (p < 0.0001), where
value of biopsy associated with sialometry was higher.
However, negative predictive value of sialometry and biopsy
associated with sialometry showed no significant differences
(p = 0.5662). Sensitivity of sialometry was higher (p = 0.0304)
than biopsy associated with sialometry, and specificity of
biopsy associated with sialometry was higher than the one
for sialometry alone (p < 0.0001).
DISCUSSION
The attempt to define criteria to make the diagnosis
of patients with Sjögren’s Syndrome has occupied the
scientific literature for many decades. It is agreed that maybe
the only reliable gold standard is the clinical judgment of an
experienced physician 12. Owing to the fact that there is no
gold standard for the diagnosis, what we try to do is to set
criteria to do so.
Classifications initially include a series of criteria and
according to the number of criteria met by the patient he/
she would be classified as having Sjögren’s Syndrome 10,13,
which generated some uncertainty for patients and difficulty
for researchers to enroll patients in scientific trials.
Another difficulty found for the definition of the
classification criteria is the small number of patients with
Sjögren’s Syndrome, which was solved by the conduction of
multicenter studies, involving different countries, conducting
exams and applying questionnaires in groups, controlling
with over 200 cases 1,7.
Owing to the fact that it is the Otorhinolaryngologist
that should get to know and identify diseases that affect the
salivary glands and those that can interfere in the production
of saliva, we tried to identify among those patients that came
to the Ambulatory of Stomathology, Department of
Otorhinolaryngology, those that really presented Sjögren’s
Syndrome. To that end, the criteria set by the European
Community Study Group on Diagnostic Criteria for Sjögren’s
Table 1. Comparison of number of foci in groups NSS, SSp and SSsec with results of sialometry.
Group Sialometry n Minimum Maximum Median Mean p Result
NSS + 16 0.00 4.80 0.00 22.8 A
NSS - 21 0.00 6.00 0.00 24.5 A
SSp + 12 0.00 9.80 5.75 50.3 0,0001 C
SSp - 5 0.00 12.00 4.10 45.1 C
SSsec + 4 0.00 3.60 0.00 25.8 A
SSsec - 4 0.00 5.90 2.25 35.3 B
(+) represents abnormal result of sialometry
(-) represent normal result of sialometry
A, B and C: groups with the same letters do not present significant differences
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Syndrome 1,7,8,11, based on the descriptive method was used.
To assess ocular impairment, Schirmer test is more frequently
used than Rose-Bengal owing to the facility to make and
the familiarity with the test technique by the
Otorhinolaryngologist, which uses it to assess patients with
facial paralysis. In the investigation of salivary gland
involvement, scintigraphy and sialometry were more used
than parotid sialography, also owing to easy execution, but
specially because they are less invasive methods.
Still regarding sialometry, the preferred technique was
salivary collection with previously weighted cotton 9, because
of its practical approach in view of the other techniques
that involve volunteer actions of patients such as spitting or
collecting saliva from the mouth.
As to sensitivity and specificity of the test described
in the literature, biopsy presented sensitivity of 82.4% and
specificity of 86.2%, and non-stimulated sialometry presented
sensitivity of 56.1% and specificity of 80.7%7. In the present
results, we observed biopsy with lower sensitivity, 72%, and
similar specificity, 83.8%, and sialometry with higher
sensitivity, 61.5%, and lower specificity, 52.2%. Probably,
these differences are caused by size of sample, but the
biopsy maintained the specificity even with smaller sample.
Biopsy was the test with higher accuracy, 89%8 and in the
present results we presented slightly lower accuracy, 79%.
We observed that the association of two positive
criteria, sialometry and biopsy, presented very high
specificity - 95%, higher than isolated biopsy. Such fact has
major importance thinking about the criteria for the
classification of patients in research studies, in which high
specificity will increase the strict criteria for inclusion of ca-
ses.
The classification of patients in this study was based
on modifications introduced by the American-European
Consensus, that is, the mandatory presence of biopsy or the
presence of auto-antibodies, among the four international
criteria for patients to be considered with primary Sjögren’s
Syndrome. Thus, to classify patients in group SSp, we
considered as mandatory the presence of biopsy or positive
auto-antibodies 11. This topic has been object of controversy
in the international literature 14. As a result, 4 patients in the
study, which would be diagnosed as Sjögren’s Syndrome,
were reclassified as NSS (19%), because they presented 4
positive criteria, but they did not present biopsy or positive
auto-antibodies. In the literature, this reclassification index
was higher 15.
Even though they are not part of the exclusion criteria
for Sjögren’s Syndrome 11, we decided to exclude one case
that met all criteria for primary Sjögren’s Syndrome, but the
patient presented Wegener’s granulomatosis. As already
described16, Wegener’s granulomatosis may be present with
salivary gland impairment, with increase in volume, possibility
of functional impairment and histopathological exam, which
is compatible with Sjögren’s Syndrome.
There is multiplicity of sialometry techniques, and
as a result, many nomenclature systems, such as salivary
flow measurements at rest, or basal flow or non-stimulated
flow. There are also many techniques of stimulation, and
in addition, many variations in relation to collection time
and normal range parameters. In the present study, we
considered only the non-stimulated sialometry values as
defined by the classification criteria. Stimulated sialometry
has a role in the assessment of glandular reserve and, thus,
the indication of the best choice in relation to hyposalivation
treatment. If there is reserve, we should make an attempt
to stimulate the gland; if not, we should prefer the use of
saliva substitutes.
As to non-stimulated salivary flow, we can use it as
drainage techniques - spit, suction and swab, with the use of
cotton 17. The adoption of swab technique 9 proved to be
practical, of low cost, easy to measure and provided
autonomy to patients’ acts, such as for example, spitting. It
seems to be important when we assess elderly patients or
those with some degree of motor impairment.
Dry mouth complaint - xerostomia, is not always
correlated with objective signals of hyposalivation 18-22. In
our study, we considered it difficult to define a correlation
between dry mouth complaint and abnormal sialometry, but
in some cases, subjects with xerostomia present sialometry
within the normal range. It may occur by a reduction of
saliva flow, which is significant for the patients, but whose
values were within the normal range, or still by reducing the
production of mucin, an abnormality in qualitative
composition of saliva. Conversely, there are subjects with
very low flows in sialometry, many times with values that
leave no doubts.
As to the idea that the elderly presented higher
prevalence of dry mouth, in fact, the elderly did not present
dry mouth owing to aging per se, but due to higher
Table 2. Values of sensitivity, specificity, positive predictive
value (VP+), negative predictive value (VP-) and accuracy
calculated for biopsy, sialometry and positive biopsy and
sialometry in groups with primary Sjögren’s Syndrome (SSp),
secondary Sjögren’s Syndrome (SSsec), both together (SS)
and non-Sjögren Syndrome.
% Biopsy Sialometry Biopsy and
sialometry
Sensitivity SSp 88.2 70.6 64.7
Sensitivity SSsec 37.5 44.4 11.1
Sensitivity SS 72.0 61.5 46.2
Specificity NSS 83.8 52.2 95.0
VP + SSp 62.5 31.6 78.6
VP + SSsec 12.5 10.5 7.1
VP + SS 75.0 42.1 85.7
VP - 81.6 70.6 73.1
Accuracy 79.0 55.6 75.8
352
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 71 (3) PART 1 MAY/JUNE 2005
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
prevalence of associated diseases and use of drugs 23-25. In
the present study, 6.5% of the patients NSS presented dia-
betes as cause of symptoms and 26.1% used medications
that caused xerostomia.
As to normal range criteria, the value of 0.1 ml/min
corresponds to the adopted classification criteria of
Sjögren’s Syndrome and it was adopted by this study19,21.
However, this value was also widely discussed by other
publications 22,25,26.
In this study, non-stimulated sialometry presented SSp
sensitivity of 70.6% and SSsec of 44.4%. Specificity was
52.2%. We observed that test performance was very different
between SSp and SSsec. When groups SSp and SSsec were
grouped in SS, sensitivity was 61.5%, somewhat higher than
what was related in the literature, and specificity was
maintained in 52.2%, lower than the one described in the
literature - 80.7%7. Such differences may also be explained
by size of sample. Positive predictive value was 42.1% and
negative predictive value (PV) was 70.6%, or in other words,
there is higher likelihood of the subject not having Sjögren’s
Syndrome when sialometry is negative. Accuracy was of
55.6%.
Minor salivary gland biopsy was maintained as an
alternative to assess salivary gland impairment in Sjögren’s
Syndrome. Morbidity is very low compared to major salivary
gland biopsy, especially with the technical modification of
isolated incision, removing the glands through the incision
27, differently from what was used, which removed a section
of the mucosa28.
Even though it is considered the highest
accuracy among the classification criteria, minor salivary
gland biopsy is also surrounded by controversy, specially
concerning the number of foci present in it that is
suggestive of Sjögren’s Syndrome. Some authors stated
that one inflammatory foci in 4mm2 of gland tissue would
be suggestive of Sjögren’s Syndrome 1,28, whereas others
stated that it would be necessary to have more than one
4mm2 focus for the diagnosis of salivary impairment in
Sjögren’s Syndrome 29-31. Others questioned the value of
the biopsy stating that similar picture could be present in
other diseases 32.
Based on the studies published by the European
Community Study Group, in special in 1993 and 1994 1, 7,
in which minor salivary gland biopsy was validated and
tested in terms of sensitivity and specificity, considering as
limit the presence of 1 focus and also more than one focus,
the authors demonstrated that gain in specificity was minor
compared to loss in sensitivity when we considered more
than one focus. Thus, there is some tendency in adopting
this limit to standardize scientific studies. In the present
study we considered the positivity of histopathological
exams with the presence of 1 or more 4mm2 foci of glan-
dular tissue.
During the review of slides of patients NSS and SS,
we observed different types of inflammatory infiltrate and
tried to grade them as mild, intermediate and severe 30; we
also counted the inflammatory foci, which is essential to
define whether the biopsy was suggestive or not of Sjögren’s
Syndrome.
We observed significant dif ference between
medians of number of foci in groups NSS (0.00), SSp (5.20)
and SSsec (0.00), that is, in fact focal sialodenitis with
higher number of foci was characteristic of primary
Sjögren’s Syndrome, confirming also the statement that
patients with secondary Sjögren’s Syndrome presented
fewer foci in biopsies 7.
The fact that the biopsy is considered a mandatory
criterion for classification of patients with primary Sjögren’s
syndrome and not mandatory for the classification of
secondary Sjögren’s syndrome may be owed to the same
fact that indirectly reflects the difference existing in both
conditions, that is, they are different laboratory and
histopathological clinical manifestations.
The comparison of number of foci in groups NSS,
SSp and SSsec, subdivided according to the results of
sialometry, either abnormal or normal, demonstrated in
Table 1, showed that there is no difference in the results
obtained in groups NSS with abnormal sialometry and nor-
mal sialometry, and SSp with abnormal sialometry and
normal sialometry. SSp group continued to have
significantly more foci, regardless of the results of
sialometry. There was difference in the group SSsec, in
which those that presented affected sialometry had results
similar to those in group NSS. Thus, we can observe that
salivary flow affections represented by abnormal sialometry
did not have any correlation with number of foci presented
in the biopsy.
Still concerning number of foci, we did not observe
any correlation between higher number of foci and higher
disease progression time, which makes us consider that the
severity of the condition and the impairment of salivary gland
are independent from duration of the disease, or in other
words, a subject that presented Sjögren’s syndrome for little
time could have had more impairment than a subject with
Sjögren’s syndrome for many years, which is controlled and
without sudden episodes.
As to role of minor salivary gland biopsy as diagnostic
criteria, we observed that it presented sensitivity of 88.2%
for SSp, quite different from the sensitivity for SSsec, which
was 37.5%, which once again reflects a very different profile
from the test in each condition. Specificity was 83.8%. When
groups SSp and SSsec were brought together in SS, we
confirmed test sensitivity of 72.0%, somewhat lower than
what was described in the literature 7, of 82.4%, and specificity
was maintained at 83.8%, quite similar to that described in
the same study, of 86.2%. It shows that test specificity was
maintained, Positive PV was 75% and Negative PV was 81.6%,
showing that a subject would have 75% likelihood of having
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Sjögren’s syndrome when biopsy was positive and 81.6%
likelihood of not having Sjögren’s syndrome when biopsy
was negative. Accuracy was 79.0%.
When tests were analyzed together, that is, positive
biopsy and sialometry, sensitivity dropped to 46.2%;
however, specificity went up to 95.0%. Positive PV was 85.7%
and Negative PV was 73.1%. Accuracy was 75.8%. We
detected expressive increase in specificity for this association.
Upon comparing biopsy and sialometry, we could
observe that specificity and Positive PV of biopsy were higher
and there was no difference between sensitivity and negative
PV. Thus, if necessary to use these tests for screening
purposes, both isolated biopsy and sialometry may be used
owing to the fact that they do not have any difference in
sensitivity.
When the comparison was made between the biopsy
and biopsy associated with sialometry, we observed that
biopsy had higher sensitivity and higher negative PV. Positive
PV did not present differences. Specificity of biopsy associated
with sialometry was higher.
Upon comparing sialometry and biopsy associated
with sialometry, we could observe that the association had
higher positive PV and higher specificity. Sensitivity of
sialometry was higher. There were no statistically significant
differences between negative PV. Once again, specificity of
biopsy plus sialometry was higher than for the isolated tests.
Therefore, we can notice that the positive results of
biopsy plus sialometry increased specificity for Sjögren’s
syndrome, differently from the situation in which they are
considered separately. We understand that loss of sensitivity
may be compensated by the use of other criteria that are
not object of the present study.
Owing to the fact that there has been no difference
between positive PV of biopsy and biopsy plus sialometry,
and that positive PV of biopsy plus sialometry is higher than
positive PV for sialometry alone, we can state that subjects
have a likelihood of 85.7% of having Sjögren’s syndrome
when both exams are positive, a likelihood that is quite
high.
Thus, if there are any limitations concerning the exams
to be performed to classify a patient, the combination of
positive biopsy and sialometry shows high chances of making
the right classification.
CONCLUSION
Based on the observations of this study, we concluded
that:
Tests of sialometry and biopsy have different
performances in patients with primary and secondary
Sjögren’s Syndrome. Sensitivity and positive predictive values
were higher for primary Sjögren Syndrome, both isolated
and together. The number of biopsy foci was also higher in
primary Sjögren’s Syndrome.
Sialometry performed with cotton technique
presented sensitivity of 61.5% and negative predictive value
of 70.6%.
Biopsy presented specificity of 83.8% and positive
predictive value of 75%.
Positive response for both criteria together increases
the specificity for Sjögren’s Syndrome (95%) when compared
to the isolated tests, which is important for the classification
of research studies. The positive predictive value of both
criteria together was 85.7%.
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